Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04379 | 33641283 | Crit Rev Oncog | Understanding the Alterations in Lipid Metabolism in NAFLD Progression: Current Trends and Future Directions. | 2021 | Details |
| A04380 | 33641248 | Liver Int | SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism. | 2021 | Details |
| A04381 | 33641244 | Liver Int | Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. | 2021 | Details |
| A04383 | 33640303 | Dig Liver Dis | Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study. | 2021 | Details |
| A04384 | 33640265 | J Diabetes Complications | Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population. | 2021 | Details |
| A04385 | 33640247 | Phytomedicine | A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats. | 2021 | Details |
| A04386 | 33639194 | Eur J Pharmacol | Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. | 2021 | Details |
| A04387 | 33639080 | Int J Med Mushrooms | In Vitro Antioxidation, Antihepatic Steatosis, and Anti-Inflammatory Effects of Ethyl Acetate Fraction from Auricularia nigricans (Agaricomycetes). | 2021 | Details |
| A04388 | 33638902 | Hepatology | Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer. | 2021 | Details |
| A04389 | 33638251 | J Gastroenterol Hepatol | Community screening identifies undiagnosed chronic liver disease in high-risk populations. | 2021 | Details |
| A04391 | 33637088 | Lipids Health Dis | Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. | 2021 | Details |
| A04392 | 33637021 | Thyroid | Comparative Analysis of the Effects of Long-Term 3,5-diiodothyronine Treatment on the Murine Hepatic Proteome and Transcriptome Under Conditions of Normal Diet and High-Fat Diet. | 2021 | Details |
| A04393 | 33636655 | Clin Res Hepatol Gastroenterol | Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort. | 2021 | Details |
| A04394 | 33636349 | Pharmacol Res | Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease. | 2021 | Details |
| A04395 | 33636024 | Hepatology | Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4α. | 2021 | Details |
| A04396 | 33635729 | Br J Radiol | Quantitative magnetic resonance imaging for chronic liver disease. | 2021 | Details |
| A04397 | 33634772 | Public Health Nutr | Higher Healthy Lifestyle Score is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and older Chinese adults: a community-based cross-sectional study. | 2021 | Details |
| A04398 | 33633748 | Front Immunol | Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease. | 2021 | Details |
| A04399 | 33633080 | J Pediatr Gastroenterol Nutr | Clinical and Esophagogastroduodenoscopy Findings in Pediatric Patients With Severe Obesity Evaluated Before Bariatric Surgery. | 2021 | Details |
| A04400 | 33632710 | Gut | From the origin of NASH to the future of metabolic fatty liver disease. | 2021 | Details |
| A04401 | 33632126 | BMC Gastroenterol | Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population. | 2021 | Details |
| A04402 | 33632113 | Endocr Metab Immune Disord Drug Targets | Effects of Metformin-Single Therapy on the Level of Inflammatory Markers in Serum of Non-Obese T2DM Patients with NAFLD. | 2022 | Details |
| A04403 | 33632105 | Curr HIV Res | Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A04404 | 33631357 | Contemp Clin Trials | RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. | 2021 | Details |
| A04405 | 33631228 | J Hepatol | Targeting cell-intrinsic metabolism for antifibrotic therapy. | 2021 | Details |
| A04406 | 33630750 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases. | 2021 | Details |
| A04407 | 33630451 | Ann Surg | Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis. | 2022 | Details |
| A04409 | 33630217 | Dig Dis Sci | Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife. | 2021 | Details |
| A04410 | 33629536 | Mol Nutr Food Res | Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial. | 2021 | Details |
| A04411 | 33628759 | Can J Gastroenterol Hepatol | Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. | 2021 | Details |
| A04412 | 33628758 | Can J Gastroenterol Hepatol | Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity. | 2021 | Details |
| A04413 | 33628620 | Oncoimmunology | Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer. | 2021 | Details |
| A04414 | 33628193 | Front Pharmacol | Fructose and Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A04415 | 33627704 | Sci Rep | The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates. | 2021 | Details |
| A04417 | 33626337 | Am J Hum Genet | Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease. | 2021 | Details |
| A04418 | 33626072 | PLoS One | Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats. | 2021 | Details |
| A04419 | 33626003 | Turk J Gastroenterol | Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway. | 2020 | Details |
| A04420 | 33622853 | mSystems | Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A04421 | 33622377 | Nutr Metab (Lond) | A comprehensive review of long non-coding RNAs in the pathogenesis and development of non-alcoholic fatty liver disease. | 2021 | Details |
| A04422 | 33622266 | BMC Gastroenterol | The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. | 2021 | Details |
| A04423 | 33622213 | Am J Chin Med | Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine. | 2021 | Details |
| A04424 | 33622003 | Ultraschall Med | Diagnostic Value of Ultrasound in Fatty Liver Disease. | 2021 | Details |
| A04425 | 33621271 | Med Ultrason | Complex ultrasound evaluation of non-alcoholic fatty liver disease. "One stop shop" with new ultrasound-based techniques. | 2021 | Details |
| A04426 | 33620426 | Biosci Biotechnol Biochem | Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis. | 2021 | Details |
| A04427 | 33619773 | Hepatology | Gene Deconvolution Reveals Aberrant Liver Regeneration and Immune Cell Infiltration in Alcohol-Associated Hepatitis. | 2021 | Details |
| A04428 | 33619282 | Nat Commun | Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation. | 2021 | Details |
| A04429 | 33618924 | Nutr Metab Cardiovasc Dis | Serum leptin as a mediator of the influence of insulin resistance on hepatic steatosis in youths with excess adiposity. | 2021 | Details |
| A04431 | 33618780 | Br J Nutr | Dietary and metabolic risk of neuropsychiatric disorders: insights from animal models. | 2021 | Details |
| A04432 | 33618508 | Clin Mol Hepatol | Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort. | 2021 | Details |
| A04433 | 33618024 | Clin Gastroenterol Hepatol | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. | 2021 | Details |
| A04436 | 33616848 | Obes Surg | Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04437 | 33616158 | Biochem J | Tracking biochemical changes induced by iron loading in AML12 cells with synchrotron live cell, time-lapse infrared microscopy. | 2021 | Details |
| A04438 | 33616081 | JCI Insight | Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans. | 2021 | Details |
| A04439 | 33616043 | J Diabetes Complications | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years. | 2020 | Details |
| A04440 | 33615993 | Gut Microbes | Modulation of the PI3K/Akt/mTOR signaling pathway by probiotics as a fruitful target for orchestrating the immune response. | 2022 | Details |
| A04441 | 33615637 | Anim Sci J | Complement C3 participates in the development of goose fatty liver potentially by regulating the expression of FASN and ETNK1. | 2021 | Details |
| A04442 | 33615471 | J Cell Physiol | A new activator of esterase D decreases blood cholesterol level through ESD/JAB1/ABCA1 pathway. | 2020 | Details |
| A04443 | 33615207 | JHEP Rep | NASH-related increases in plasma bile acid levels depend on insulin resistance. | 2020 | Details |
| A04444 | 33615164 | ACS Pharmacol Transl Sci | Cytotoxicity, Retention, and Anti-inflammatory Effects of a CeO2 Nanoparticle-Based Supramolecular Complex in a 3D Liver Cell Culture Model. | 2020 | Details |
| A04445 | 33614318 | Cureus | Treatment of Fatty Liver Disease: The Present and the Future. | 2021 | Details |
| A04446 | 33613940 | Frontline Gastroenterol | Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver disease. | 2020 | Details |
| A04448 | 33612679 | Intern Med | Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm Study. | 2021 | Details |
| A04449 | 33612041 | Chronobiol Int | Different expressions of clock genes in fatty liver induced by high-sucrose and high-fat diets. | 2021 | Details |
| A04450 | 33612037 | Expert Rev Clin Pharmacol | Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis. | 2021 | Details |
| A04451 | 33611063 | Int Immunopharmacol | Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages. | 2021 | Details |
| A04453 | 33610041 | Biochem Biophys Res Commun | Inhibition of Notch1 signaling reduces hepatocyte injury in nonalcoholic fatty liver disease via autophagy. | 2021 | Details |
| A04454 | 33609576 | Int J Biol Macromol | Synthesis of a green bigel using cottonseed oil/cannabis oil/alginate/ferula gum for quercetin release: Synergistic effects for treating infertility in rats. | 2021 | Details |
| A04455 | 33609335 | J Cosmet Dermatol | Non-alcoholic fatty liver and lipid profile status in patients with melasma: A case-control study. | 2021 | Details |
| A04456 | 33609303 | Hepatology | Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling. | 2021 | Details |
| A04457 | 33609166 | Abdom Radiol (NY) | Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification. | 2021 | Details |
| A04458 | 33608323 | Dis Model Mech | High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. | 2021 | Details |
| A04459 | 33608215 | HPB (Oxford) | Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature. | 2021 | Details |
| A04460 | 33608033 | Nutr Metab (Lond) | Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals. | 2021 | Details |
| A04461 | 33606661 | Eur J Endocrinol | Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study. | 2021 | Details |
| A04462 | 33606428 | J Clin Gastroenterol | Effect of Statin Use on Cancer-related Mortality in Nonalcoholic Fatty Liver Disease: A Prospective United States Cohort Study. | 2022 | Details |
| A04463 | 33605666 | J Pediatr Gastroenterol Nutr | Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. | 2021 | Details |
| A04464 | 33604259 | J Clin Transl Hepatol | Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. | 2021 | Details |
| A04465 | 33604257 | J Clin Transl Hepatol | Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally. | 2020 | Details |
| A04466 | 33604254 | J Clin Transl Hepatol | Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail. | 2020 | Details |
| A04467 | 33604251 | J Clin Transl Hepatol | HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters. | 2021 | Details |
| A04468 | 33604250 | J Clin Transl Hepatol | Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A04469 | 33603948 | Oxid Med Cell Longev | Bixin Attenuates High-Fat Diet-Caused Liver Steatosis and Inflammatory Injury through Nrf2/PPARα Signals. | 2021 | Details |
| A04470 | 33603909 | Maedica (Bucur) | Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms. | 2020 | Details |
| A04471 | 33603899 | Maedica (Bucur) | Triple Antioxidant Therapy, an Alternative for Patients with Chronic Liver Disease - A Prospective Multicenter Interventional Study. | 2020 | Details |
| A04472 | 33603757 | Front Immunol | Extracellular Vesicles as Inflammatory Drivers in NAFLD. | 2021 | Details |
| A04473 | 33603714 | Front Endocrinol (Lausanne) | Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. | 2021 | Details |
| A04474 | 33603666 | Front Pharmacol | The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A04475 | 33602617 | J Diabetes Complications | Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis. | 2021 | Details |
| A04476 | 33602481 | Clin Res Hepatol Gastroenterol | A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy. | 2020 | Details |
| A04477 | 33602203 | BMC Endocr Disord | Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients. | 2021 | Details |
| A04478 | 33601426 | Exp Clin Endocrinol Diabetes | Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus. | 2021 | Details |
| A04479 | 33601216 | Nutr Res | G protein-coupled receptors: Key molecules in metabolic associated fatty liver disease development. | 2020 | Details |
| A04480 | 33601157 | J Pharm Biomed Anal | Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing. | 2021 | Details |
| A04481 | 33601024 | Endocr Pract | Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients. | 2021 | Details |
| A04482 | 33600604 | J Gastroenterol Hepatol | Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model. | 2021 | Details |
| A04483 | 33600104 | Clin Transl Gastroenterol | Implications of Abdominal Adipose Tissue Distribution on Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: A Chinese General Population Study. | 2021 | Details |
| A04487 | 33599159 | Expert Opin Pharmacother | An update on pharmacotherapeutic strategies for obesity. | 2021 | Details |
| A04488 | 33598647 | JHEP Rep | Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. | 2020 | Details |
| A04489 | 33598160 | Food Sci Nutr | The protective effect of sulforaphane on type II diabetes induced by high-fat diet and low-dosage streptozotocin. | 2020 | Details |
| A04490 | 33598084 | Pan Afr Med J | Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes. | 2020 | Details |